← Back to All Filings

Labcorp EVP Bryan T. Vaughn Reports RSU Vesting and Routine Tax Withholding

Low SignificanceNovember 3, 2026 at 10:36:43 AM EST

LABCORP HOLDINGS INC.

$LH4CIK: 0000920148

Subscribe to track LH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ SEC Form 4 Filing | Labcorp Holdings Inc. ($LH)

Insider: Bryan T. Vaughn (EVP and President, Diagnostics) Filing Date: November 3, 2026 Transaction Date: November 1–2, 2026

Summary of Transactions: • Acquisition (Code M): 500 shares acquired via RSU vesting ($0.00/share) • Disposition (Code F): 194 shares withheld for tax obligations at $355.59/share ($68,984.46 total) • Net Addition: +306 shares • Post-Transaction Holdings: 7,150.9105 shares

Significance: Low (Routine compensation vesting and mandatory tax withholding)

Comprehensive Analysis

Executive Summary

On November 3, 2026, Labcorp Holdings Inc. ($LH) filed a Form 4 disclosing equity award activity by Bryan T. Vaughn, EVP and President of Diagnostics. The filing covers the vesting of 500 Restricted Stock Units (RSUs) on November 1, 2026, and the subsequent automatic withholding of 194 shares of common stock on November 2, 2026, to satisfy tax withholding requirements.

Transaction Breakdown

  1. RSU Vesting (Code M):

    • Date: November 1, 2026
    • Security: Common Stock
    • Shares Acquired: 500 shares at $0.00 conversion price
  2. Tax Withholding (Code F):

    • Date: November 2, 2026
    • Security: Common Stock
    • Shares Disposed: 194 shares
    • Price Per Share: $355.59
    • Total Value Withheld: $68,984.46
  3. Post-Transaction Direct Ownership:

    • Common Stock: 7,150.9105 shares (net increase of 306 shares from the vesting event; total includes 99.3403 shares previously acquired under the 2025 Employee Stock Purchase Plan).
    • Remaining RSUs: 4,704 derivative units.

Market and Trading Impact Assessment

  • Trading Significance: Low
  • Rationale: This transaction reflects scheduled equity award settlement rather than open-market discretionary trading. The disposition was entirely a standard tax-withholding transaction (Code F) administered by the issuer. Consequently, this filing does not provide directional signaling regarding company performance.
Topics:#Labcorp#LH#InsiderTrading#SECForm4#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.